• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number BXAL087901J
Device Problems Positioning Failure (1158); Difficult to Insert (1316)
Patient Problems Aneurysm (1708); Perforation of Vessels (2135); Obstruction/Occlusion (2422)
Event Date 08/02/2023
Event Type  Injury  
Manufacturer Narrative
C1: cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H3: code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2023, the patient underwent an endovascular treatment of an abdominal aortic aneurysm with iliac aneurysm using gore® excluder® aaa endoprostheses and a gore® viabahn® vbx balloon expandable endoprosthesis (vbx).After an iliac branch component was placed on the right side of the patient, an internal iliac component was inserted into the right internal iliac artery.The catheter insertion was difficult due to the angled vessel, and the iliac branch component was re-positioned slightly proximal and the internal iliac component was deployed.The vbx was subsequently inserted for extend into the superior gluteal artery.The catheter insertion was difficult due to the angled vessel, and the vbx was deployed near bifurcation of the superior and inferior gluteal arteries.After touching up with a non-gore balloon (gekira), a vessel perforation was confirmed near bifurcation of the superior and inferior gluteal arteries.The balloon occlusion was performed near the proximal of the iliac branch component, and the superior gluteal artery up to the internal iliac component was all embolized with coil and plug.After confirming hemostasis, the planned procedure was proceeded and the patient tolerated the procedure.
 
Manufacturer Narrative
Emdr section h6 e, a, b, c, d codes were updated to reflect results of investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
samir kulovic
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key17611251
MDR Text Key321826417
Report Number2017233-2023-04226
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberBXAL087901J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/02/2023
Initial Date FDA Received08/24/2023
Supplement Dates Manufacturer Received08/02/2023
Supplement Dates FDA Received12/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/27/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
Patient SexFemale
-
-